|Bid||0.00 x 2200|
|Ask||0.00 x 1000|
|Day's Range||13.79 - 14.20|
|52 Week Range||12.60 - 17.67|
|Beta (5Y Monthly)||1.06|
|PE Ratio (TTM)||11.10|
|Earnings Date||Apr 26, 2022 - May 02, 2022|
|Forward Dividend & Yield||0.56 (3.43%)|
|Ex-Dividend Date||Nov 09, 2021|
|1y Target Est||17.00|
Arcus Biosciences Inc. (NYSE:RCUS) will replace Investors Bancorp Inc. (NASD:ISBC) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, April 7. S&P 500 constituent Citizens Financial Group Inc. (NYSE: CFG) is acquiring Investors Bancorp in a deal expected to be completed soon pending final closing conditions.
Citizens Financial Group, Inc. (NYSE: CFG) ("Citizens") and Investors Bancorp, Inc. (NASDAQ: ISBC) ("Investors") today announce that the expected close date of the previously announced merger between the two companies is April 6, 2022, subject to the satisfaction or waiver of the remaining customary closing conditions set forth in the merger agreement.
Citizens Financial Group, Inc. (NYSE: CFG) ("Citizens") and Investors Bancorp, Inc. (NASDAQ: ISBC) ("Investors") today announced receipt of regulatory approval from the Board of Governors of the Federal Reserve System and the Office of the Comptroller of the Currency to complete the previously announced acquisition of Investors.